BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 6270317)

  • 1. Enhancement of the 5-HT neurotransmission by antidepressant treatments.
    De Montigny C
    J Physiol (Paris); 1981; 77(2-3):455-61. PubMed ID: 6270317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological assessment of the effects of antidepressant treatments on the efficacy of 5-HT neurotransmission.
    Blier P; de Montigny C; Chaput Y
    Clin Neuropharmacol; 1988; 11 Suppl 2():S1-10. PubMed ID: 2846168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antidepressant treatments on 5-HT neurotransmission: electrophysiological and clinical studies.
    de Montigny C; Blier P
    Adv Biochem Psychopharmacol; 1984; 39():223-39. PubMed ID: 6087626
    [No Abstract]   [Full Text] [Related]  

  • 4. Electroconvulsive shock treatments enhance responsiveness of forebrain neurons to serotonin.
    de Montigny C
    J Pharmacol Exp Ther; 1984 Jan; 228(1):230-4. PubMed ID: 6319668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression.
    Blier P; de Montigny C; Chaput Y
    J Clin Psychopharmacol; 1987 Dec; 7(6 Suppl):24S-35S. PubMed ID: 3323264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of long-term administration of the antidepressant drug milnacipran on serotonergic and noradrenergic neurotransmission in the rat hippocampus.
    Weiss M; Blier P; de Montigny C
    Life Sci; 2007 Jun; 81(2):166-76. PubMed ID: 17568622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sustained (+/-)pindolol administration on serotonin neurotransmission in rats.
    Haddjeri N; Blier P
    J Psychiatry Neurosci; 2000 Sep; 25(4):378-88. PubMed ID: 11022403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic antidepressant treatment alters serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons.
    Zhong P; Yan Z
    Neuroscience; 2004; 129(1):65-73. PubMed ID: 15489029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and cellular mechanisms of antidepressant drugs.
    Owens MJ
    Depress Anxiety; 1996-1997; 4(4):153-9. PubMed ID: 9166647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of subchronic antidepressant drug treatment on central serotonergic mechanisms in the male rat.
    Fuxe K; Ogren SO; Agnati LF; Andersson K; Eneroth P
    Adv Biochem Psychopharmacol; 1982; 31():91-107. PubMed ID: 7080902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term alpha-2 adrenergic antagonists and electroconvulsive treatments on the alpha-2 adrenoceptors modulating serotonin neurotransmission.
    Mongeau R; de Montigny C; Blier P
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1152-9. PubMed ID: 7912278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of brain serotonergic receptor mechanisms for the action of antidepressant drugs.
    Ogren SO; Fuxe K; Agnati L
    Pharmacopsychiatry; 1985 Mar; 18(2):209-13. PubMed ID: 3927330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased tonic activation of rat forebrain 5-HT(1A) receptors by lithium addition to antidepressant treatments.
    Haddjeri N; Szabo ST; de Montigny C; Blier P
    Neuropsychopharmacology; 2000 Apr; 22(4):346-56. PubMed ID: 10700654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bupropion: a review of its mechanism of antidepressant activity.
    Ascher JA; Cole JO; Colin JN; Feighner JP; Ferris RM; Fibiger HC; Golden RN; Martin P; Potter WZ; Richelson E
    J Clin Psychiatry; 1995 Sep; 56(9):395-401. PubMed ID: 7665537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of 5-hydroxytryptamine release from rat midbrain raphe nuclei by 5-hydroxytryptamine1D receptors: effect of tetrodotoxin, G protein inactivation and long-term antidepressant administration.
    Piñeyro G; Blier P
    J Pharmacol Exp Ther; 1996 Feb; 276(2):697-707. PubMed ID: 8632339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrophysiologic tests for testing the effects of antidepressant drugs and corticosterone on reactivity of serotonin receptors in the hippocampus].
    Zahorodna A; Tokarski K; Bijak M
    Postepy Hig Med Dosw; 2000; 54(3):391-401. PubMed ID: 10941273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressants and serotonergic neurotransmission: an integrative review.
    Willner P
    Psychopharmacology (Berl); 1985; 85(4):387-404. PubMed ID: 2410942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
    Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
    Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Can a serotonin uptake agonist be an authentic antidepressant? Results of a multicenter, multinational therapeutic trial].
    Kamoun A; Delalleau B; Ozun M
    Encephale; 1994; 20(5):521-5. PubMed ID: 7828515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.